Adriamycin (Doxorubicin) Cardiotoxicity: A Review

Por Chlebowski, Rowan T.
Publicado em 1979

Vitamin D and breast cancer: interpreting current evidence

Por Chlebowski, Rowan T
Publicado em 2011

Changing Concepts: Menopausal Hormone Therapy and Breast Cancer

Por Chlebowski, Rowan T., Anderson, Garnet L.
Publicado em 2012

Menopausal Hormone Therapy and Cancer: Changing Clinical Observations of Target Site Specificity

Por Chlebowski, Rowan T., Anderson, Garnet L.
Publicado em 2014

Menopausal hormone therapy and breast cancer mortality: clinical implications

Por Chlebowski, Rowan T., Anderson, Garnet L.
Publicado no Ther Adv Drug Saf (2015)

Weight Loss Randomized Intervention Trials in Female Cancer Survivors

Por Chlebowski, Rowan T., Reeves, Marina M.
Publicado no J Clin Oncol (2016)

Obesity and Cancer: Insights for Clinicians

Por Goodwin, Pamela J., Chlebowski, Rowan T.
Publicado no J Clin Oncol (2016)

Intentional weight loss and cancer risk

Por Luo, Juhua, Hendryx, Michael, Chlebowski, Rowan T.
Publicado no Oncotarget (2017)

Utility of Two Cancer Organization Websites for a Multiethnic, Public Hospital Oncology Population: Comparative Cross-Sectional Survey

Por Nguyen, Katherine D, Hara, Belinda, Chlebowski, Rowan T
Publicado em 2005

Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence

Por Col, Nananda F, Kim, Jung A, Chlebowski, Rowan T
Publicado em 2005

Alcohol use and breast cancer survival among participants in the Women's Health Initiative

Por Lowry, Sarah J., Kapphahn, Kris, Chlebowski, Rowan, Li, Christopher I.
Publicado no Cancer Epidemiol Biomarkers Prev (2016)

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index

Por Chlebowski, Rowan T., Anderson, Garnet L., Aragaki, Aaron K., Prentice, Ross
Publicado no J Natl Cancer Inst (2015)

Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-medicare data from 1993 to 2005

Por Yasmeen, Shagufta, Chlebowski, Rowan T, Xing, Guibo, Morris, Cyllene R, Romano, Patrick S
Publicado em 2013

Aromatase Inhibitor, Tamoxifen and Endometrial Cancer in Breast Cancer Survivors

Por Chlebowski, Rowan T., Schottinger, Joanne E., Shi, Jiaxiao, Chung, Joanie, Haque, Reina
Publicado no Cancer (2015)

Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women

Por Wu, Yanyuan, Sarkissyan, Marianna, Clayton, Sheilah, Chlebowski, Rowan, Vadgama, Jaydutt V.
Publicado no Cancers (Basel) (2017)

Body Mass Index and Waist Circumference in Relation to Lung Cancer Risk in the Women's Health Initiative

Por Kabat, Geoffrey C., Kim, Mimi, Hunt, Julie R., Chlebowski, Rowan T., Rohan, Thomas E.
Publicado em 2008

HIP BONE DENSITY PREDICTS BREAST CANCER RISK INDEPENDENTLY OF GAIL SCORE-RESULTS FROM THE WOMEN’S HEALTH INITIATIVE

Por Chen, Zhao, Arendell, Leslie, Aickin, Mikel, Cauley, Jane, Lewis, Cora E., Chlebowski, Rowan
Publicado em 2008

Meta-analysis of Vascular and Neoplastic Events Associated with Tamoxifen

Por Braithwaite, R Scott, Chlebowski, Rowan T, Lau, Joseph, George, Suzanne, Hess, Rachel, Col, Nananda F
Publicado em 2003

Diabetes and Lung Cancer Among Postmenopausal Women

Por Luo, Juhua, Chlebowski, Rowan, Wactawski-Wende, Jean, Schlecht, Nicolas F., Tinker, Lesley, Margolis, Karen L.
Publicado em 2012

SNPs and breast cancer risk prediction for African American and Hispanic women

Por Allman, Richard, Dite, Gillian S., Hopper, John L., Gordon, Ora, Starlard-Davenport, Athena, Chlebowski, Rowan, Kooperberg, Charles
Publicado no Breast Cancer Res Treat (2015)